Clinical Update on RAS Targeting In CRC
Time: 2:30 pm
day: Day Two Track F
Details:
- Multiple clinical trials are ongoing in CRC to explore the efficacy of RAS targeting, with varying degrees of effica
- Mechanisms of adaptive resistance are prevalent, and preclinical studies can guide rational combinations
- Based on experience to date, combinations will be needed in most settings for CRC patients
